Caplin Point Labs subsidiary gets US FDA nod for Ephedrine Sulfate Injection

Caplin Point Laboratories said that its subsidiary Caplin Steriles has been granted final approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Ephedrine Sulfate Injection.